lysosomal glutathione A rational design of a cancer-specific and lysosome-targeted fluorescence nanoprobe for imaging in living cells L-Glutathione reduced (GSH) | Antioxidant

Toxins 6, 11931200

reported that most clinical trials testing c-MET inhibitors in cancer have yielded little benefit to patients and have not adequately tested the concept of c-MET pathway inhibition due to the lack of appropriate patient selection criteria ( Taken together, while the overall prognosis for CRC, especially in the metastatic setting, remains poor due to the intrinsic and acquired resistance to chemotherapy, targeted therapy, and immunotherapy, advances in our understanding of the resistance mechanisms of mCRC paved the way for new targeted biologic therapies and small molecules in both preclinical and clinical stages of development

Turnbull, J

10.2147/OTT.S208781 73 WeiP

Meanwhile, the R 2 substitution allowed modulating the level of biological activity, finding the most active and selective response for the R 1 -substitution of 4-bromo-, 4-chloro-, or, eventually, 3,4,5-trimethoxy-